Stock Market

Corporate ESG factors — that means environmental, social and governance considerations — are quickly becoming a metric to measure investment decisions. So, when asset managers with $10 trillion under their watch raise a red flag about a company’s exposure to physical climate risks, investors need to take notice. ESG stocks are not going away anytime
0 Comments
As you may be aware, some business combinations with special purpose acquisition companies (SPACs) have not gone well. But one exception — at least so far — is eFFECTOR Therapeutics (NASDAQ:EFTR) and EFTR stock. Source: Shutterstock This clinical-stage biotechnology firm focuses on selective translation regulation inhibitors (STRIs) in cancer. EFTR stock is currently up some
0 Comments
Robinhood (NASDAQ:HOOD) stock looks great again, and the company’s management responded by pushing ahead with a cryptocurrency wallet. This puts it in competition with a host of companies including Coinbase (NASDAQ:COIN). The company is also thinking of adding crypto assets to its balance sheet, which could boost HOOD stock. Source: OpturaDesign / Shutterstock.com Unlike Robinhood’s original
0 Comments
When was the last time you seriously thought about investing in a Swiss shoemaker? Probably never, but there’s a unique opportunity here as On Holding (NYSE:ONON) is no ordinary sneaker manufacturer and ONON stock is a fast mover. Source: shutterstock.com/New Africa The company’s initial public offering (IPO) just recently took place, and InvestorPlace contributor Brenden Rearick opined
0 Comments
Joby (NYSE:JOBY) appears to have most of the ingredients necessary to enable JOBY stock to (pardon the pun) eventually take off. Source: T. Schneider / Shutterstock.com Specifically, the air-taxi company has proven technology, a service that should generate strong demand, a highly accomplished CEO, impressive backers and a fairly reasonable valuation. When it comes to
0 Comments
What would happen if a company developed a massive new product and no one cared? For Pfizer’s (NYSE:PFE) investors, that has been the question for the past year. Despite coming up with a blockbuster vaccine for the novel coronavirus, PFE stock did basically nothing for an extended period. Source: Manuel Esteban / Shutterstock.com That finally changed
0 Comments